GPNMB and frontotemporal dementia: Before assessing the effects of GPNMB knock-down on PBMC immune cell function and lysosomal homeostasis in FTD-GRN and control groups, the GPNMB-targeting ASO (Ionis) was first optimized in healthy control samples.